Featured Research

from universities, journals, and other organizations

Patients who refuse prostate cancer surgery have worse long-term survival, study finds

Date:
June 2, 2010
Source:
Henry Ford Health System
Summary:
Men who refuse surgery for prostate cancer and instead opt for "watchful waiting" have a significantly worse long-term survival rate than those patients that choose radiotherapy, according to researchers. The study found that patients who refused any treatment for their prostate cancer had a 10-year overall survival rate of 51 percent, compared to 68 percent for those who chose radiation treatment.

Men who refuse surgery for prostate cancer and instead opt for "watchful waiting" -- monitoring cancer progression without undergoing treatment -- have a significantly worse long-term survival rate than those patients that choose radiotherapy, according to researchers at Henry Ford Hospital in Detroit.

The study found that patients who refused any treatment for their prostate cancer had a 10-year overall survival rate of 51 percent, compared to 68 percent for those who chose radiation treatment.

"Surgery has been shown to offer a survival advantage to patients with prostate cancer when compared with other treatment options. However, a significant number of patients refuse surgery and instead opt for other treatments such as radiotherapy," says study lead author Naveen Pokala, M.D., an urologist at Henry Ford Hospital.

The study was presented at the 2010 American Urology Association's annual meeting in San Francisco.

These findings follow a study published by Dr. Pokala in 2009 that showed surgery improves 5-, 10- and 15-year survival rates for men younger than 50 with moderately and especially in poorly differentiated prostate cancers, when compared with other standard treatments such as radiation therapy or watchful waiting.

The new research, a population-based analysis of 9,704 patients chosen from the National SEER database, looked at survival rates among men with a mean age of 64.4 years, of whom 77 percent were white and 16.4 percent black.

Of that group, nearly 30 percent refused any treatment for their prostate cancers, and about 70 percent chose radiation therapy.

Within the group, 6 percent had well-differentiated cancers, 75 percent moderately differentiated cancers, and 18 percent had poorly differentiated cancer.

More than 70 percent of the patients were unmarried. In all, African American men older than 65 had the worst prognosis.

Prostate cancer is second only to skin cancer as the most common cancer in American men, affecting one in six during his lifetime. The majority of the cases are in men older than 65, but it is becoming more prevalent in men under 40.

It affects black men twice as often as whites, and their mortality rate is also twice as high.

While curable in its early stages, symptoms often don't appear until the cancer has spread beyond the prostate gland itself, so annual exams for the disease are recommended.

In addition to Dr. Pokala, study co-authors at Henry Ford Hospital included James Peabody, M.D., and Mani Menon, M.D.


Story Source:

The above story is based on materials provided by Henry Ford Health System. Note: Materials may be edited for content and length.


Cite This Page:

Henry Ford Health System. "Patients who refuse prostate cancer surgery have worse long-term survival, study finds." ScienceDaily. ScienceDaily, 2 June 2010. <www.sciencedaily.com/releases/2010/06/100601114633.htm>.
Henry Ford Health System. (2010, June 2). Patients who refuse prostate cancer surgery have worse long-term survival, study finds. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2010/06/100601114633.htm
Henry Ford Health System. "Patients who refuse prostate cancer surgery have worse long-term survival, study finds." ScienceDaily. www.sciencedaily.com/releases/2010/06/100601114633.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins